JB Pharma reports revenue growth of 9 per cent to Rs 882 crores in Q2 FY24
PAT increased by 36 per cent to Rs 151 crores
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
JB Chemicals & Pharmaceuticals
JB Pharma publishes its second ESG report for FY 2022-23
JB Pharma reported 19 per cent decrease in GHG intensity as compared to last year
JBCPL forays into nephrology segment in India with new division called RENOVA
JBCPL to launch seven products in the division that will focus on the management of hypertension in Chronic Kidney Disease to…
JB Chemicals & Pharmaceuticals appoints Nikhil Chopra as CEO
The Board of directors of JB Chemicals & Pharmaceuticals appointed Nikhil Chopra as Whole-time Director and Chief Executive…